HISTOGENICS CORP Business Operations Contracts & Agreements

13 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
At Market Issuance Sales Agreement, dated June 10, 2022, by and among Ocugen, Inc., Cantor Fitzgerald & Co., Mizuho Securities USA LLC, H.C. Wainwright & Co., LLC, Roth Capital...
Sales Agreements
HISTOGENICS CORP
Biotechnology
NY
2022
Second Amendment to Co-Development, Supply and Commercialization Agreement, dated as of April 15, 2022, by and between the Registrant and Bharat Biotech International Limited
Supply Agreements
HISTOGENICS CORP
Biotechnology
2022
Development and Commercial Supply Agreement, dated September 29, 2021, by and between the Registrant and Bharat Biotech International Limited
Development Agreements
HISTOGENICS CORP
Biotechnology
2021
First Amendment to Co-Development, Supply and Commercialization Agreement, dated as of May 29, 2021, by and between the Registrant and Bharat Biotech International Limited
Supply Agreements
HISTOGENICS CORP
Biotechnology
2021
Co-Development, Supply and Commercialization Agreement, dated as of January 31, 2021, by and between the Registrant and Bharat Biotech International Limited
Supply Agreements
HISTOGENICS CORP
Biotechnology
2021
At Market Issuance Sales Agreement, dated August 14, 2020, by and among Ocugen, Inc., Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc
Sales Agreements
HISTOGENICS CORP
Biotechnology
NY
2020
Controlled Equity OfferingSM Sales Agreement, dated June 12, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co
Sales Agreements
HISTOGENICS CORP
Biotechnology
NY
2020
Controlled Equity OfferingSM Sales Agreement, dated May 8, 2020, by and between Ocugen, Inc. and Cantor Fitzgerald & Co
Sales Agreements
HISTOGENICS CORP
Biotechnology
NY
2020
Letter of Understanding, dated November 8, 2017, between The Regents of the University of Colorado and Ocugen, Inc
MOUs
HISTOGENICS CORP
Biotechnology
2019
Form of Ocugen Voting Agreement, dated April 5, 2019, by and between Histogenics, Ocugen and each of the parties named in each agreement therein
Voting Agreements
HISTOGENICS CORP
Biotechnology
DE
2019
Form of Histogenics Voting Agreement, dated April 5, 2019, by and between Ocugen, Histogenics and each of the parties named in each agreement therein
Voting Agreements
HISTOGENICS CORP
Biotechnology
DE
2019
Mutual Termination and Release Agreement dated December 21, 2018, between Histogenics Corporation and Intrexon Corporation
Termination Agreements
HISTOGENICS CORP
Biotechnology
DE
2018
CONFIDENTIAL TREATMENT REQUESTED AMENDMENT TO LICENCE AGREEMENT Made and entered in to this 23rd day of March 2010 By and between YEDARESEARCH AND DEVELOPMENT COMPANY LIMITED
Development Agreements
HISTOGENICS CORP
Biotechnology
2014